
Oliver Zivanovic, MD, PhD
Surgeon
Titles
Director, Innovative Surgical Technology, Gynecology Service, Department of Surgery
Clinical Expertise
Uterine, Cervical, Ovarian, and Vulvar Cancers; Cytoreductive Surgery; Peritonectomy Procedures; Hyperthermic Intraoperative Intraperitoneal Chemoperfusion; Fertility-Sparing Surgery
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Zivanovic accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type:
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type:
In Network Coverage Type(s): PPO, HMO
Payor Type:
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type:
In Network Coverage Type(s): HMO
Payor Type:
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type:
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type:
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type:
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type:
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Contact and Location
- 212-639-7033 Office Phone
- Follow Dr. Zivanovic on Twitter
- Speaks English, German, and Serbo-Croatian

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, Johannes Gutenberg University
Residencies
Obstetrics and Gynecology - Bonn University School of Medicine
Fellowships
Gynecologic Oncology - Memorial Sloan Kettering Cancer Center; Breast Medicine/Gynecologic Oncology - Bonn University School of Medicine
Board Certifications
Obstetrics/Gyecology (Germany): Gynecologic Oncology (Germany)
I am a gynecologic oncology surgeon with ten years of experience in caring for women with ovarian cancer, uterine cancer, cervical cancer, and vulvar cancer. I perform about 250 procedures each year using a variety of techniques, including minimally invasive approaches. At Memorial Sloan Kettering, we are able to combine our experience and expertise both in and out of the operating room — working closely with our colleagues in pathology, medical oncology, and radiation oncology — to provide better outcomes than ever for women with gynecologic diseases.
Read more
I come from a family of doctors, so I naturally developed an interest in medicine. After completing my fellowship at MSK, there was no question that I would devote my professional life to helping people with cancer. I decided to focus my clinical practice on gynecologic diseases because they can be complex surgical cases requiring a great amount of skill and focus to treat successfully.
In the operating room, I have particular expertise in performing cytoreductive surgery for women with advanced ovarian cancer. The goal of this procedure is to remove as much visible disease as possible, making the tumor more responsive to chemotherapy and improving the chances of successful treatment. In addition, I have extensive experience in surgically treating uterine cancer. When appropriate, I use minimally invasive techniques (laparoscopy and robotics) to reduce recovery time so that patients can get back to their lives sooner. I am also skilled at performing risk-reducing surgery for women who have breast cancer, ovarian cancer, and endometrial cancer in their families and who may have a higher chance of developing these diseases.
The main focus of my research has been to establish and evaluate how we can use hyperthermic intraperitoneal chemoperfusion (HIPEC) to improve outcomes for women with advanced ovarian cancer. HIPEC delivers heated chemotherapy into the abdominal cavity, where it attacks the diseased tissue directly. I am also involved in patient-centered research, in which we ask patients to evaluate how we are doing and provide suggestions on what we can do improve the treatment experience. The goal of this research is to make communication between physicians and patients after surgery easier, and ultimately help patients recover faster.
I also support ovarian cancer research at MSK by running the New York City Marathon with Fred’s Team. If you would like to donate or learn more, please visit my page.
Though I partner closely with my colleagues on MSK’s Gynecologic Oncology Service and our ovarian cancer service, Team Ovary, my most important teammates are my patients and their families. It’s my job to provide expert surgical care, but in order for this to happen, I need to work with my patients to decide on the best approach to treating their specific disease. I provide my patients with all the information they need in order to feel empowered about making decisions related to their care, taking into account individual circumstances, concerns, and fears. Together, we craft a plan that we can be confident will lead to the best possible outcome.
Outside of the office, I enjoy spending time with my family, running, listening to classical music and jazz, and surfing in the Rockaways.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Zivanovic
- A Phase III Study of Surgery with or without Hyperthermic Intraperitoneal Chemotherapy in People with Ovarian Cancer
- Clinical Trials Co-Investigated by Dr. Zivanovic
- A Study Comparing Robotic-Assisted Laparoscopy and Laparotomy for Radical Hysterectomy in People with Cervical Cancer

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Zivanovic O, Chi DS, Zhou Q, Iasonos A, Konner JA, Makker V, Grisham RN, Brown AK, Nerenstone S, Diaz JP, Schroeder ED, Langstraat CL, Paroder V, Lakhman Y, Soldan K, Su K, Gardner GJ, Andikyan V, Guo J, Jewell EL, Long Roche K, Troso-Sandoval T, Lichtman SM, Moukarzel LA, Dessources K, Abu-Rustum NR, Aghajanian C, Tew WP, Beumer J, Sonoda Y, O’Cearbhaill RE. Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study. J Clin Oncol. 2021 Aug 10;39(23):2594-2604. doi: 10.1200/JCO.21.00605. Epub 2021 May 21. PMID: 34019431; PMCID: PMC8330970.
Jiménez-Sánchez A, Memon D, Pourpe S, Veeraraghavan H, Li Y, Vargas HA, Gill MB, Park KJ, Zivanovic O, Konner J, Ricca J, Zamarin D, Walther T, Aghajanian C, Wolchok JD, Sala E, Merghoub T, Snyder A, Miller ML. Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient. Cell. 2017 Aug 24;170(5):927-938.e20. doi: 10.1016/j.cell.2017.07.025. PMID: 28841418; PMCID: PMC5589211.
Zivanovic O, Chen LY, Vickers A, Straubhar A, Baser R, Veith M, Aiken N, Carter J, Curran K, Simon B, Mueller J, Jewell E, Chi DS, Sonoda Y, Abu-Rustum NR, Leitao MM Jr. Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study. Gynecol Oncol. 2020 Oct;159(1):187-194. doi: 10.1016/j.ygyno.2020.07.004. Epub 2020 Jul 24. PMID: 32718730; PMCID: PMC7380930.
Visit PubMed for a full listing of Dr. Zivanovic’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Oliver Zivanovic discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].